Evaluating the protective effect of dapsone on experimental osteoarthritis models induced by MIA in male rats
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgae087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Kimia Nazari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Pharmacology, School of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Dapsone, NF-kappa B, Interleukin-1beta, Osteoarthritis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Tehran University of Medical Sciences.
Abstract (Originalsprache)
Objectives
Osteoarthritis, a degenerative condition that results in significant morbidity, is typically managed with treatments aimed at symptom relief rather than addressing the underlying degeneration. Dapsone, recognized for its anti-inflammatory, antioxidant, antiexcitotoxic, and antiapoptotic properties, has demonstrated promising effects in various neurodegenerative diseases. This study explores the potential of dapsone to mitigate articular destruction, inflammation, and pain in rat models of osteoarthritis.
Methods
Osteoarthritis was induced in rats by injecting MIA into the right knee joint. Dapsone was then administered intraperitoneally at 5, 10, or 20 mg/kg every 2 days for 2 weeks. Behavioural tests were done on days 0, 7, and 14. On day 14, the articular cartilage was histologically analysed using H&E staining. Serum levels of NF-kB, IL-1β, and TNF-α were evaluated by ELISA.
Results
Dapsone effectively reduces pain, inflammation, and articular cartilage damage in osteoarthritis. Specifically, it improves mechanical allodynia and thermal hyperalgesia, reduces inflammatory markers (TNF-α, IL-1β, and NF-κB), and protects against cartilage destruction and chondrocyte loss, with the most significant effects at 20 mg/kg.
Conclusions
Dapsone effectively prevents pain, inflammation, and cartilage damage in osteoarthritis rats, suggesting its potential as a therapeutic option for managing osteoarthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology and Pharmacology, School of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Pain Research Center, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Experimental Medicine Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Oral and Maxillofacial Radiology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Hamed Shafaroodi
Förderung
- Tehran University of Medical Sciences
Zitieren
APA
Nazari, K., Hosseindoost, S., Dehpour, A. R., Kheirandish, Y., & Shafaroodi, H. (2024). Evaluating the protective effect of dapsone on experimental osteoarthritis models induced by MIA in male rats. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae087
Vancouver
Nazari K, Hosseindoost S, Dehpour AR, Kheirandish Y, Shafaroodi H. Evaluating the protective effect of dapsone on experimental osteoarthritis models induced by MIA in male rats. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae087
BibTeX
@article{Nazari2024,
author = {Nazari, Kimia and Hosseindoost, Saereh and Dehpour, Ahmad Reza and Kheirandish, Yasaman and Shafaroodi, Hamed},
title = {Evaluating the protective effect of dapsone on experimental osteoarthritis models induced by MIA in male rats},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgae087}
}
EUVIMED